{"id":"W2058736678","doi":"10.1038/bjc.2012.543","title":"Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis","year":2013,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; Genentech; Bayer HealthCare; Exelixis; Sanofi; Pfizer","keywords":"Sorafenib; Tolerability; Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Cumulative incidence; Incidence (geometry); Dosing; Population; Oncology; Confidence interval; Cohort; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000235232,0.000213841,0.0008509498,0.0002436292,0.00005214971,0.00006340477,0.0001428944,0.00009482165,0.0005784591],"category_scores_gemma":[0.00007787148,0.0001838187,0.0002914649,0.0005967914,0.00004950186,0.0003135228,0.00002903839,0.0004356,0.000007916407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005004521,"about_ca_system_score_gemma":0.0002874263,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009340326,"about_ca_topic_score_gemma":0.006255962,"domain_scores_codex":[0.9974565,0.0001228809,0.0009537776,0.0003680498,0.0007064366,0.0003923868],"domain_scores_gemma":[0.9978805,0.00008809177,0.0006019433,0.000295074,0.0008257071,0.0003086811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003214611,0.001286701,0.9441307,0.00003338086,0.0007535687,0.001132077,0.0003344604,0.000472209,0.0008068913,2.376215e-7,0.0006232851,0.04721186],"study_design_scores_gemma":[0.02070507,0.001109757,0.9733219,0.0002956935,0.001499241,0.00003557921,0.0001022429,0.00007122975,0.002337657,0.00002527777,0.0003158786,0.0001805456],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935412,0.004800058,0.00005086315,0.0002535341,0.00008762002,0.0005030495,0.0002669577,0.000008841705,0.0004879104],"genre_scores_gemma":[0.9980107,0.0001394875,0.001225375,0.0001379744,0.0001232262,0.00003447035,0.0001079861,0.00002600551,0.0001947754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04703132,"threshold_uncertainty_score":0.9972566,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006884527369790601,"score_gpt":0.2310847486887122,"score_spread":0.2242002213189216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}